Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Nat Commun ; 13(1): 2138, 2022 04 19.
Article in English | MEDLINE | ID: mdl-35440644

ABSTRACT

The accurate and efficient cleavage of shRNAs and pre-miRNAs by DICER is crucial for their gene-silencing activity. Here, we conduct high-throughput DICER cleavage assays for more than ~20,000 different shRNAs and show the comprehensive cleavage activities of DICER on these sequences. We discover a single-nucleotide bulge (22-bulge), which facilitates the cleavage activity of DICER on shRNAs and human pre-miRNAs. As a result, this 22-bulge enhances the gene-silencing activity of shRNAs and the accuracy of miRNA biogenesis. In addition, various single-nucleotide polymorphism-edited 22-bulges are found to govern the cleavage sites of DICER on pre-miRNAs and thereby control their functions. Finally, we identify the single cleavage of DICER and reveal its molecular mechanism. Our findings improve the understanding of the DICER cleavage mechanism, provide a foundation for the design of accurate and efficient shRNAs for gene-silencing, and indicate the function of bulges in regulating miRNA biogenesis.


Subject(s)
MicroRNAs , RNA Precursors , Humans , Gene Silencing , MicroRNAs/chemistry , MicroRNAs/genetics , Ribonuclease III/metabolism , RNA Precursors/genetics , RNA, Small Interfering/genetics , Polymorphism, Single Nucleotide
2.
RNA Biol ; 18(11): 1716-1726, 2021 11.
Article in English | MEDLINE | ID: mdl-33382955

ABSTRACT

MicroRNAs (miRNAs) play critical roles in gene expression and numerous human diseases. The success of miRNA biogenesis is largely determined by the primary miRNA (pri-miRNA) processing by the DROSHA-DGCR8 complex, called Microprocessor. Here, we analysed the high-throughput pri-miRNA processing assays and secondary structures of pri-miRNAs to investigate the roles of bulges in the pri-miRNA processing. We found that bulges in multiple places control both the cleavage efficiency and accuracy of pri-miRNA processing. These bulges were shown to act on Microprocessor via its catalytic subunit, DROSHA, and function in a position and strand-dependent manner. Interestingly, we discovered that the enriched and conserved bulges, called midB, can correct DROSHA orientation on pri-miRNAs, thereby enhancing production of miRNAs. The revealed functions of the bulges help improve our understanding of pri-miRNA processing and suggest their potential roles in miRNA biogenesis regulation.


Subject(s)
MicroRNAs/chemistry , MicroRNAs/genetics , Nucleic Acid Conformation , RNA-Binding Proteins/metabolism , Ribonuclease III/metabolism , Base Pairing , Base Sequence , HEK293 Cells , Humans , MicroRNAs/metabolism , RNA Processing, Post-Transcriptional , RNA-Binding Proteins/genetics , Ribonuclease III/genetics
3.
Mol Cell Biochem ; 473(1-2): 167-177, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32638255

ABSTRACT

An active metabolite of vitamin A, all-trans retinoic acid (ATRA), is known to exert immunomodulatory functions. This study investigates the possible immune potentiating effect of ATRA on NF-κB activity in human monocytic THP-1 cells after exposure to unmethylated CpG DNA ODN2006. We observed that challenge with ODN2006 significantly enhanced the NF-κB activity of PMA-differentiated THP-1 cells. ATRA synergistically enhanced NF-κB activity of cells, in a concentration- and time-dependent manner. The enhanced NF-κB activity of PMA-differentiated THP-1 cells after ODN2006 challenge was dependent on the RAR/RXR pathway. To determine the mechanism involved in increasing in the NF-κB activity of stimulated THP-1 cells, we examined the effects of PMA and ATRA on the expression of TLR9 (a receptor of ODN2006) in THP-1 cells. PMA treatment significantly enhanced both the intracellular and cell surface expression of TLR9, while ATRA alone showed no effect. However, ATRA synergistically enhanced the cell surface TLR9 expression of PMA-differentiated cells. To determine whether the ATRA-enhanced NF-κB activity is due to the enhanced cell surface TLR9 expression, we examined NF-κB activity after treatment with anti-TLR9 blocking antibody. Results revealed that the anti-TLR9 antibody treatment almost completely reverses the ATRA-enhanced NF-κB activity, suggesting that ATRA enhances NF-κB activity through upregulation of the cell surface TLR9 expression in PMA-differentiated and unmethylated CpG challenged THP-1 cells.


Subject(s)
Gene Expression Regulation/drug effects , NF-kappa B/metabolism , Oligodeoxyribonucleotides/pharmacology , Signal Transduction/drug effects , Tetradecanoylphorbol Acetate/pharmacology , Toll-Like Receptor 9/biosynthesis , Tretinoin/pharmacology , Humans , NF-kappa B/genetics , Signal Transduction/genetics , THP-1 Cells , Toll-Like Receptor 9/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...